When Risk Management Plans Ignore Australian Context.
Published on: 08/02/2026
What happens when Risk Management Plans treat Australian patients as European by default? The safety implications of inadequate local adaptation.
pharmacovigilance

What happens when Risk Management Plans treat Australian patients as European by default? The safety implications of inadequate local adaptation.

GMP Annex 22 sets new rules for AI in pharma manufacturing, linking with Annex 11 and Chapter 4 to define validation, data governance, and inspector expectations for compliant, explainable, and risk-based AI use in GMP environments.